Breakthrough Mental Healing image

Breakthrough Mental Healing

We help patients unlock the healing power of the mind through Psychedelic Inspired Medicines & Experiential Therapies.

Together we can overcome.

MindMed Reports Topline Data From Phase 1 Trial of MM-110 in Development for the Treatment of Opioid Withdrawal featured image
05/19/22

MindMed Reports Topline Data From Phase 1 Trial of MM-110 in Development for the Treatment of Opioid Withdrawal

We’re a New Kind of Pharma Company

Patients and therapists deserve care that transcends traditional symptom management cycles, advancing long-term mental healing.

View our approach

Our Healing Goes Beyond Just A Pill

01

Discover

Rigorous science of novel psychedelic compounds, therapies, and healing technologies in collaboration with leading institutions and researchers to make faster discoveries, together

02

Develop

Conducting clinical trials of psychedelic inspired medicines and experiential therapies within existing regulatory pathways to ensure the most effective & transformative healing experience possible

03

Deploy

We hold ourselves and our products to the highest levels of safety, efficacy, and accessibility so psychedelic inspired medicines and experiential therapies can one day reach patients in need

Quotation Marks

MindMed named one of 36 startups that could change the world

MindMed could have the key to providing the upsides of psychedelic drugs for both focus and addiction treatment—while cutting out the downsides of tripping.”

We have the right people for the right reasons.

Our interdisciplinary team of drug development veterans, savvy technologists, and mental health experts was purpose-built to tackle these challenges. With over a century of combined experience in product development and commercialization, we have the know-how and the heart to introduce a better approach to mental health.

Robert Barrow Portrait

Robert Barrow

Chief Executive Officer and Board Director

Miri Halperin Wernli, PhD Portrait

Miri Halperin Wernli, PhD

Executive President and Board Director

Cynthia Hu, JD Portrait

Cynthia Hu, JD

Chief Legal Officer & Corporate Secretary

Daniel R Karlin, MD MA Portrait

Daniel R Karlin, MD MA

Chief Medical Officer

Francois P. Lilienthal, MD, MBA Portrait

Francois P. Lilienthal, MD, MBA

Chief Commercial Officer

Robert Malenka, MD PhD Portrait

Robert Malenka, MD PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Peter Bergethon, MD Portrait

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Dworkin, PhD Portrait

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Maurizio Fava, MD Portrait

Maurizio Fava, MD

Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Maria A Oquendo, MD PhD Portrait

Maria A Oquendo, MD PhD

Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania

Bryan L Roth, MD PhD Portrait

Bryan L Roth, MD PhD

Professor of Pharmacology, University of North Carolina School of Medicine; Director of the National Institute of Mental Health Psychoactive Drug Screening Program

Kenneth Alper, MD Portrait

Kenneth Alper, MD

Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine

Peter Gasser, MD Portrait

Peter Gasser, MD

Clinical Advisor

Stanley D Glick, MD PhD Portrait

Stanley D Glick, MD PhD

Scientific Advisor

Matthew W Johnson, PhD Portrait

Matthew W Johnson, PhD

Clinical Advisor

Kim PC Kuypers, PhD Portrait

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Matthias Liechti, MD PhD Portrait

Matthias Liechti, MD PhD

Scientific Collaborator & Advisor

Sarah McCallum, PhD Portrait

Sarah McCallum, PhD

Associate Professor of Neuroscience and Experimental Therapeutics (DNET) at Albany Medical College

Natalie Wheeler, PhD Portrait

Natalie Wheeler, PhD

Medical Science Liaison with Dova Pharmaceuticals

John Rotrosen, MD Portrait

John Rotrosen, MD

Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry

Carol Vallone Portrait

Carol Vallone

Chair of the Board of Directors, Chair of Compensation Committee, Member of Audit/Finance Committee

Andreas Krebs Portrait

Andreas Krebs

Vice Chair of the Board of Directors, Chair of Nomination and Governance Committee, Member of Audit/Finance Committee

Sarah Y Vinson, MD Portrait

Sarah Y Vinson, MD

Board Director, Member of Compensation, Nomination, and Governance Committees

Brigid Makes Portrait

Brigid Makes

Board Director, Chair of Audit/Finance Committee, Member of Compensation Committee, Member of Nomination and Governance Committee

JR Rahn Portrait

JR Rahn

Co-Founder

Stephen L Hurst, JD Portrait

Stephen L Hurst, JD

Co-Founder

Scott Freeman, MD Portrait

Scott Freeman, MD

Co-Founder

Leonard Latchman Portrait

Leonard Latchman

Co-Founder

Carrie Liao, CPA Portrait

Carrie Liao, CPA

VP, Corporate Controller & Accounting Principal